The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of STK11 mutation on first-line immune checkpoint inhibitor (ICI) outcomes in a real-world KRAS G12C mutant lung adenocarcinoma cohort.
 
Rebecca Suk Heist
Honoraria - Chugai/Roche
Consulting or Advisory Role - Apollomics; Boehringer Ingelheim; Daichii Sankyo; Daichii Sankyo; EMD Serono/Merck; EMD Serono/Merck; Novartis; Tarveda Therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); Exelixis (Inst); Exelixis (Inst); Incyte (Inst); Lilly (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst); Turning Point Therapeutics (Inst)
 
Junhua Yu
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Elifnur Yay Donderici
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Nicole Zhang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Carin R. Espenschied
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Kathryn Lang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Dialectica
Travel, Accommodations, Expenses - Guardant Health
 
Beata Korytowsky
Employment - Bristol-Myers Squibb; Mirati Therapeutics; Pfizer
Stock and Other Ownership Interests - BMSi; Mirati Therapeutics; Pfizer
 
Andrew S. Chi
Employment - Mirati Therapeutics; Neon Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics
Patents, Royalties, Other Intellectual Property - Fused Bicyclic Heterocycles as Therapeutic Agents (Inventor) Provisional Patent Application No. 62/742,041 filed on October 5, 2018; Methods for the treatment of lung cancers, provisional patent application filed October 2020.
 
James G Christensen
Employment - Mirati Therapeutics
Leadership - BCTG Acquisition Corporation; Mirati Therapeutics
Stock and Other Ownership Interests - BCTG Acquisition Corporation; Bluebird Bio; Mirati Therapeutics
Consulting or Advisory Role - BridgeBio Pharma
Patents, Royalties, Other Intellectual Property - Multiple patents in last 2 years while employed at Mirati Therapeutics covering discovery of KRAS, LSD1, and EZH2 inhibitors. (Inst)